AI & dataHuman trial
A resource of data and samples in cognitively unimpaired 60–75‐year‐olds at increased risk of Alzheimer's disease based on their APOE4 status as heterozygotes or homozygotes
AAIC 2025 Abstract
Abstract
Background: The Alzheimer's Prevention Initiative (API)Generation Program studies were sponsored by Novartis and Amgen, in partnership with Banner Alzheimer's Institute and with support from the U.S. National Institute on Aging and Banner.
The paper
Christopher T. Brown, Jessica Enos, Carolyn M. Langlois, Eric M. Reiman
Show 7 more authors
Trisha L. Walsh, Hayley Salata, Yi Su, Vivek Devadas, Jeremy J. Pruzin, Jessica B. S. Langbaum, Pierre N. Tariot,Banner Alzheimer’s Institute
AAIC 2025 Abstract · 25 Dec 2025 · CC BY
Presented at AAIC 2025
